The company reported an overall sequential revenue growth of 117 percent compared with the fourth quarter of 2009, according to the release. Revenue for the three months ended March 31, 2010 was $22.5 million, compared with $23.9 million for the same period last year. Excluding client services and private label DBM revenue, first quarter 2010 revenue was $21.6 million compared with $21.1 million in the first quarter of 2009 with the increase in revenue reflecting sales of new products during the first quarter of 2010.
Osteotech recently launched nationally its FacetLinx Fusion Technology, which it believes will continue to drive growth in the second quarter, according to the release.
Read the release on Osteotech's first quarter earnings.
Osetotech Announces First Quarter EarningsWritten by Staff | May 11, 2010
Osteotech, a leader in the emerging field of biologic products for regenerative healing, reported financial results for the first quarter ended March 31, 2010, which included the launch of the company's Plexur M Innovated Grafting and MagniFuse Bone Graft products, according to an Osteotech news release.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.